France vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Cause of death, by non-communicable diseases, ages 5-14

France
64.5%
in 2021
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
30.8%
in 2021
France rank
20th
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
22nd

Cause of death, by non-communicable diseases, ages 5-14 over time

  • France
  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
0204060200020102021

How they compare

France currently reports 64.5% against 30.8% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 33.7%.

That makes France's figure about 2.1 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

Across all 6 years both countries report, France has been ahead every year.

France ranks 20th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 22nd of 185 countries.

France has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade France Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Difference Ahead
2000s 51.7% 25.6% 26.1% France
2010s 65.8% 27.2% 38.5% France
2020s 63.4% 30.1% 33.3% France

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cause of death, by non-communicable diseases, ages 5-14, France or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
France, at 64.5% against 30.8% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2021.
What is the difference in cause of death, by non-communicable diseases, ages 5-14 between France and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
33.7%, with France ahead.
How many years of comparable data are there for France and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
6 years are reported by both, from 2000 to 2021.
How do France and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for cause of death, by non-communicable diseases, ages 5-14?
France ranks 20th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 22nd of 185 countries.
Where does this data come from?
Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

France vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Cause of death, by non-communicable diseases, ages 5-14. Statizoid, drawing on Global Health Estimates, World Health Organization (WHO). Retrieved 19 September 2026, from https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-5-14-percent-of-total-deaths-ages-5-14/france/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-5-14-percent-of-total-deaths-ages-5-14/france/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/">France vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Cause of death, by non-communicable diseases, ages 5-14</a> — Statizoid

About this data

Indicator
Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14)
Unit
% of total deaths ages 5-14
Source
Global Health Estimates, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 1,392 data points, 2000–2021
Last refreshed

Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.